Mainz Biomed (NASDAQ:MYNZ – Get Free Report) and Mercury Systems (NASDAQ:MRCY – Get Free Report) are both industrials companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, valuation and institutional ownership.
Analyst Recommendations
This is a summary of recent ratings for Mainz Biomed and Mercury Systems, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Mainz Biomed | 1 | 1 | 0 | 0 | 1.50 |
| Mercury Systems | 2 | 4 | 6 | 1 | 2.46 |
Mercury Systems has a consensus target price of $107.90, suggesting a potential upside of 46.70%. Given Mercury Systems’ stronger consensus rating and higher probable upside, analysts plainly believe Mercury Systems is more favorable than Mainz Biomed.
Earnings & Valuation
This table compares Mainz Biomed and Mercury Systems”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Mainz Biomed | $659,935.00 | 9.80 | -$21.65 million | ($65.60) | -0.01 |
| Mercury Systems | $983.62 million | 4.55 | -$29.67 million | ($0.50) | -147.10 |
Mainz Biomed has higher earnings, but lower revenue than Mercury Systems. Mercury Systems is trading at a lower price-to-earnings ratio than Mainz Biomed, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Mainz Biomed and Mercury Systems’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Mainz Biomed | N/A | N/A | N/A |
| Mercury Systems | -3.02% | 1.29% | 0.78% |
Risk & Volatility
Mainz Biomed has a beta of 0.31, meaning that its share price is 69% less volatile than the S&P 500. Comparatively, Mercury Systems has a beta of 0.98, meaning that its share price is 2% less volatile than the S&P 500.
Insider & Institutional Ownership
96.0% of Mercury Systems shares are held by institutional investors. 18.2% of Mainz Biomed shares are held by company insiders. Comparatively, 1.0% of Mercury Systems shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Summary
Mercury Systems beats Mainz Biomed on 10 of the 15 factors compared between the two stocks.
About Mainz Biomed
Mainz Biomed N.V. develops and sells in-vitro diagnostic tests for the early detection of cancer in the United States. The company offers ColoAlert, a colorectal cancer diagnostic molecular genetic stool test. It also develops PancAlert, a stool-based screening test for the detection of pancreatic cancer. The company was founded in 2008 and is based in Mainz, Germany.
About Mercury Systems
Mercury Systems, Inc., a technology company, manufactures and sells components, products, modules, and subsystems for aerospace and defense industries in the United States, Europe, and the Asia Pacific. Its products and solutions are deployed in approximately 300 programs with 25 defense contractors and commercial aviation customers. The company offers components, including power amplifiers and limiters, switches, oscillators, filters, equalizers, digital and analog converters, chips, monolithic microwave integrated circuits, and memory and storage devices; modules and sub-assemblies, such as embedded processing boards, switched fabrics and boards, digital receivers, multi-chip modules, integrated radio frequency and microwave multi-function assemblies, tuners, and transceivers, as well as graphics and video boards; and integrated subsystems. It also designs and develops digital radio frequency memory units for various modern electronic warfare applications; radar environment simulation and test systems for defense and intelligence applications; and signals intelligence payloads and EO/IR technologies for small UAV platforms, as well as onboard UAV processor systems for real-time wide area motion imagery. The company was formerly known as Mercury Computer Systems, Inc. and changed its name to Mercury Systems, Inc. in November 2012. The company was incorporated in 1981 and is headquartered in Andover, Massachusetts.
Receive News & Ratings for Mainz Biomed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mainz Biomed and related companies with MarketBeat.com's FREE daily email newsletter.
